ClinicalTrials.gg
CompletedNCT04574271Updated Sep 19, 2024

Multidimensional Intervention in Pre-frail Patients Older Than 70 Years

An interventional study of Intensive dietary advice and exercise prescription and Usual dietary advice and exercise prescription in Frail Elderly Syndrome and Sarcopenia, sponsored by Endocrinology and Clinical Nutrition Research Center, Spain. Completed at 1 site in Spain. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Endocrinology and Clinical Nutrition Research Center, Spain · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jun 2019, registered Sep 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
340
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Study summary

Aging represents a huge advance in society and a health and social challenge. Spain has one of the highest life expectancies in the world, but other countries with the same demographic characteristics are ahead of us in quality adjusted life years. Primary care setting has the main drivers of healthy aging, acting on the early stages of pre-frailty and frailty.

Therefore, it is proposed a multicomponent intervention (nutritional and prescription of physical exercise) in patients older than 70 years of the Medina del Campo Health Center, with pre-frailty criteria, in order to measure the changes that this intervention produces in their mild dysfunction and whether it is capable of reversing it or delaying the progression to a state of frailty.

Read the detailed description

Hypothesis: A balanced diet, with a sufficient protein intake for each patient based on the Mediterranean diet, as well as the performance of multicomponent exercise 3 times a week, delays the evolution to stages of dysfunction or disability in the pre-frail population.

Objective:

  • The main objective is to evaluate the effect of an intensive nutritional dietary treatment on the function markers in a sample of elderly people in a situation of pre-frailty.
  • To Demonstrate the equivalence of the values obtained in terms of functional improvement through adequate exercise and diet in urban populations in a semi-urban population.
  • To evaluate the change in analytical markers that indicate pre-frailty in patients under intensive dietary-nutritional treatment.
  • To Study the improvement of quality of life in individuals with adequate nutrition and level of physical exercise in those over 70 years of age in pre-frailty stages, increasing the prevalence of healthy aging in our study population.

Methods:

  • Design: This is a quasi-experimental study with a control group. Recruitment will be carried out, through random sampling, of patients over 70 years of age from the basic health area of Medina del Campo Urbano, detecting those who meet Fried's pre-frailty criteria, through the FRAIL questionnaire, being positive for pre-frailty fulfilling 1 or 2 criteria. These subjects detected as pre-frail will be randomly included in different multicomponent programs. In a group, two types of interventions will be carried out by the research team from primary care: Dietary advice adjusted to the needs of the patient and their pre-frailty stage, with an adequate nutritional and protein intake, based on the scientific evidence existing to date and in collaboration with the Clinical Hospital of Valladolid, Spain; and a multicomponent physical exercise prescription (elasticity, strength, resistance and balance), of at least 150 minutes per week, according to the WHO recommendations for this age group, adapting it individually, to be performed 3-5 times per week. Both branches of the intervention will be carried out through periodic interviews throughout a year of follow-up.

In the control group, the nutritional advice and prescription of regular physical exercise will be developed by the health team of the primary care center.

During this year, the parameters to be measured of functionality and independence, as well as anthropometric, quality of life and corresponding analytical parameters will be evaluated prior to the beginning of the intervention. Evaluating their variation at 3 months, 6 months and one year in both groups.

  • Sample Size: It has been calculated to estimate a proportion similar to that of the population. Based on the prevalence of 50% existing in other study samples in the national territory for pre-frailty, and thus choosing the position of maximum indeterminacy (p = 50), assuming normality, for an α = 0.05 the Measure of the resulting sample calculated was 338 individuals.
  • Chronogram:

Selection of patients: june 2019. Phone recruiting of patients: june 2019 Clinical and functional assessment will be carried out in Medina del Campo Health Center and randomization: july 2019-August 2019.

Intervention (First Time): October-december 2019; january-february 2020; july-august 2020; september-october 2020.

Follow up: Evaluation of parameters. July-August 2020; september-october 2020; november-december 2020; january-february 2021.

Statistycal Analysis: March-April 2021 Drafting of results: May-June 2021

02

Conditions studied

  • Frail Elderly Syndrome
  • Sarcopenia

Browse trials for

03

In context

Sarcopenia

1,329 studies on the registry are indexed under Sarcopenia; 420 are open to participants now.

This study's enrollment of 340 is above the median of 60 across 855 interventional studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

Endocrinology and Clinical Nutrition Research Center, Spain is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non-institutionalized patients over 70 years of age from the basic health area of Medina del Campo Urbano, who meet pre-frailty criteria (1 or 2 Fried criteria).

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment
  • Frailty syndrome
  • Moderate-Severe Dependence
  • less than 6 months or patients in palliative care
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
340 participants (actual)

Study arms

  • Experimental
    Intensive dietary advice and exercise prescription

    Personalized dietary advice and exercise prescription according to nutritional status.

    Behavioral: Intensive dietary advice and exercise prescription

  • Active comparator
    Usual dietary advice and exercise prescription

    Generalized dietary advice and exercise prescription in elder subjects.

    Behavioral: Usual dietary advice and exercise prescription

Interventions

  • BehavioralIntensive dietary advice and exercise prescription

    Personalized dietary advice and exercise prescription according to nutritional status.

    Also known as: Personalized dietary advice and exercise prescription

  • BehavioralUsual dietary advice and exercise prescription

    Generalized dietary advice and excercise prescription in elder patients.

06

What researchers measure

Primary outcomes

  1. Functional assessment by Fried Criteria

    Test of frail syndrome diagnosis in elder patients (Three out five criteria)

    Time frame: 12 months

  2. Fall Risk by test up and go

    Functional tests of frail syndrome diagnosis in elder patients (\<10 seconds: low fall risk; 10-20 seconds: fragility (risk of fall); \>20 seconds: high risk of fall).

    Time frame: 12 months

  3. The Lawton Instrumental Activities of Daily Living (IADL) Scale

    Functional tests of frail syndrome diagnosis in elder patients (Grade of depedence: \<20: Total; 20-35: Severe; 40-55: Moderate; \>60: Mild; 100: Independent).

    Time frame: 12 months

  4. Barthel Test for dependency

    Functional tests of frail syndrome diagnosis in elder patients

    Time frame: 12 months

Secondary outcomes

  1. Mini-Mental Test

    Cognitive evaluation (0-14: severe cognitive impairment; 15-19: moderate cognitive impairment; 20-24 mild cognitive impairment; 25-30: soft deficit of cognitive function; 30-35: normal).

    Time frame: 12 months

  2. Short Form 36 (SF-36) Health survey Questionnaire

    Questionnaire to measure quality of life (0-100 --\> 0=worst health status - 100=better health status).

    Time frame: 12 months

07

Study locations

1 site
  • Cristina Gutiérrez-Lora
    Medina del Campo, Valladolid 47400, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2019 to primary completion in Jun 2022, 36 months.

Of 492 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's 36 months is above that.

Counting every sponsor, half of 503 studies reached it within 18 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2020
First posted
Oct 5, 2020
StartActual
Jun 1, 2019
Primary completionActual
Jun 30, 2022
CompletionActual
Dec 30, 2022
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04574271
Lead sponsor
Endocrinology and Clinical Nutrition Research Center, Spain
Responsible party
Daniel de Luis Roman (Professor, MD, PhD, Endocrinology and Clinical Nutrition Research Center, Spain) — Principal investigator
First posted
Oct 5, 2020
Start date
Jun 1, 2019
Primary completion
Jun 30, 2022
Completion
Dec 30, 2022
Last update
Sep 19, 2024

Study contacts

Juan J LOPEZ-GOMEZ, MD; PhD
principal investigator · Hospital Clínico Universitario de Valladolid
Daniel A De Luis Román, MD; PhD
study director · University of Valladolid
Cristina Gutiérrez-Lora, MD
principal investigator · Primary Care Center (Medina del Campo (Valladolid, Spain))

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion